Introduction
Lung cancer is the leading cause of cancer death for men in China (1) and the incidence is increasing worldwide. Although cigarette smoking is accepted as the major cause of lung cancer, only 10-15% of heavy smokers ultimately develop lung cancer (2) . This implies that genetic variation in sensitivity to carcinogen exposure may play an important role in the etiology of lung cancer.
variant nucleotide interferes with splicing from exon 4 to exon 5 because of its unique localization within a conserved splice donor region and the A allele can produce more altered transcripts due to the altered splicing. Although both the normal and the altered transcripts encode a protein that contains amino acids thought to be responsible for the cyclin D1 function, the protein encoded by the altered transcript may have a longer halflife. Therefore, it has been suggested that DNA damage in cells from subjects with the A allele may bypass the G1/S checkpoint more easily than damage in cells not carrying the polymorphism. Recently, studies have showed that subjects with the AA genotype had higher risk to urinary bladder cancer (12) and squamous cell carcinoma of the head and neckthan those with the other two genotypes (13) .
Because cyclin D1 plays a critic role in cell cycle control and it is associated with risk of lung cancer, we conducted a hospital-based case-control study of 182 newly diagnosed lung cancer patients and 185 health controls to test the hypothesis that the G/A CCND1 polymorphism may modulate individual susceptibility to lung cancer. All patients were diagnosed histologically with specimens obtained from biopsy or surgical resection. Demographic and epidemiological data, including tobaccog use, were gathered by questionnaire completed by trained interviewers and reviewed by a single reviewer during the hospitalization. The healthy controls were recruited from a community in Beijing during a similar time period. These control subjects were first surveyed by means of a short questionnaire to determine their willingness to participate in research studies. Using the same questionnaire as for the cases, the same interview group interviewed eligible subjects and collected the data including age, sex and smoking status.
Materials and methods

Study subjects
After informed consent was obtained, a one-time 2 ml of blood sample was obtained from all participates and stored at -70 o C for genotype analysis. The study was approved by our Institutional Review Conmmittee.
Genotyping
Genomic DNA were obtained from blood by the routine high salt method (14) . The DNA purity and concentration were determined by spectrophotometric measurement of absorbance at 260 and 280 nm.
PCR based single-strand conformation polymorphism (SSCP) analysis was used to genotype the CCND1 polymorphism in exon 4 (13 For SSCP analysis, 4 µl PCR product was mixed with 4 µl of loading buffer (95% formamide, 20 mM EDTA, 0.05% xylene cyanol and 0.05% bromphenol blue). The mixture was denatured at 95 for 10 min and then immediately put on ice. Five microliters of the mixture were loaded on a 5% polyacrylamide gel for electrophoresis at 1.5 W for 5 hours. After electrophoresis the band shift patterns on gels were visualized by silver staining. Sequencing analysis was used to confirm the genotype. Based on these band shift patterns and sequencing results subjects were divided into three groups for CCND1 genotypes, GG, GA and AA. (Fig 1) Furthermore, 10% sample's genotypes were re-tested for quality control.
Statistical analysis
Subjects who had smoked more than 100 cigarettes in their lifetime were defined as smokers. The observed genotype frequencies were compared with those calculated from 
Results
There were 182 lung cancer cases and 185 controls included in this analysis. Table 1 summarizes selected characteristics of the subjects. The cases and controls were frequency matched by sex and smoking status. However, there were significantly more cases than controls in the >50 years' group (P = 0.041). The G/A single base pair polymorphism in CCND1 could reportedly influence tumor susceptibility in several cancers (22) (23) (24) (25) . The AA homozygotes express more altered transcript than the GG homozygotes and GA heterozygotes and the altered transcript fails to be spliced at the exon 4/intron 4 boundary, which does not contain exon 5 and terminates downstream of exon 4 (26) . This results in an altered protein that lacks the destruction box encoded by exon 5, which is responsible for the increasing half-life of the cyclin D1 protein (11) . Therefore, in individuals with the AA genotype, there are increasing steady-state levels cyclin D1 protein, allowing cells to pass through the G1/S checkpoint more easily and promoting the transformation of cells. Zheng and colleagues (13) have showed that the frequency of the AA genotype was higher in SCCHN patients (23.6%) than in controls (16.5%) in non-Hispanic white population and that subjects with AA genotype tended to develop SCCHN at an earlier age than those with GG genotype.
Recently the A allele of CCND1 was shown to be associated with an early age at onset of hereditary non-polypsis colorectal cancer, acting as a risk modifying gene (28) .
Furthermore, study in non-small cell lung cancer patients showed that the event-free survival was longer in patients with GG genotype (11), which indicated that the CCND1 G/A polymorphism was associated with clinical outcome of lung cancer. Similar results were found in ovarian cancer (29) and SCCHN (30) . In agreement with those studies, we found that the CCND1 AA genotype was associated with a higher risk for lung cancer in a Chinese population and this risk is remarkably increased in younger subjects. This finding is consistent with Zheng's result in SCCHN. For an early age of onset of disease is a hallmark of genetic predisposition, these results imply that the CCND1 G/A polymorphism may play a role in the susceptibility to carcinogenesis of lung cancer.
An interesting result was obtained when we divided the cases into subgroups by histological types. There were no significant associations in the subgroups except for squamous cell lung cancer patients. This finding is consistent with previous reports about cyclin D1 overexpression in squamous cell lung carcinomas (31,32). According to epidemiological studies, which have showed that smoking was the major cause of squamous cell lung cancer in Chinese (33) and the PAH-adduct was one of the main DNA damage of smoking-caused lung cancer (34), there was indication that the CCND1 G/A polymorphism might be due to the individual susceptibility to some specific environmental carcinogens or DNA damages, although the specific relationship between of cyclin D1 protein and PAH hasn't been reported. This result also provides an explanation of the result of sex stratification. A significant higher risk of subjects with the AA genotype was found in males, but not in females, because compared with 33.6% male squamous cell lung cancer cases, only 11.8% female patients in our study were squamous cell lung cancer, and smoking was not a risk factor in females. It seems that the CCND1 G/A polymorphism may not be a susceptibility marker for lung cancer of women in this population, but larger studies are needed to confirm this finding.
In conclusion, we found that the CCND1 G/A polymorphism may contribute to the susceptibility to lung cancer, especially in those who were young and males, in this Chinese population. In addition, the polymorphism may be a link in the smoking-DNA damage-lung cancer interaction. However, bias may arise from the unmatched age and limited numbers in the sub-groups analyzed and possible selection bias inherent in a hospital-based case-control study. Therefore, these results remain preliminary and need to be validated in larger and well-designed studies. 
